CRON - Cronos Group Inc.
Flavors with rare cannabinoid formulations from SOURZ by Spinach®, along with a new limited-time offer flavor, are now available in the popular multipack format Flavors with rare cannabinoid formulations from SOURZ by Spinach®, along with a new limited-time offer flavor, are now available in the popular multipack format
TORONTO, July 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 second quarter earnings conference call on Thursday, August 6, 2026 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.
For investors looking to make more green, marijuana stocks may be the way to go. Contrary to the doubt or fear based on the past, the cannabis industry is growing at a fast pace. Now, with cannabis classified as a Class 3 substance, there is very little barrier for legal operators. What that means is now there can be more product research and testing.
As the cannabis sector continues to grow, it has marijuana stock investors seeing green. There has been a long, volatile battle for most of the time cannabis companies have been publicly traded. Even during the moments when many used pot stocks to get quick profits, given how the sector once began. At one point, a great deal of hype and speculation fueled investors in taking up positions for particular cannabis stocks.
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has appointed ATB Capital Markets Corp. (“ATB Cormark”) to act as its broker in connection with share repurchases over the facilities of the TSX or other alternative Canadian trading systems, in place of Virtu Canada Corp., under its previously announced share repurchase program.
Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.
TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the “Meeting”), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.24% of the total number of common shares of the Company outstanding.
TORONTO, June 22, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos" or the "Company") today announced that at its Annual Meeting of Shareholders held on Thursday, June 18, 2026 (the "Meeting"), shareholders holding a total of 271,828,759 common shares of the Company voted in person or by proxy, representing 72.
A lot is going on in the cannabis industry between the USA and Canadian markets. As more people and companies prepare for the road ahead with the rescheduling of cannabis. This has put a lot of pressure on legal operators to make the necessary adjustments to remain compliant. However, this also impacts marijuana stock investors both in the short and long term.
TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has filed with the Toronto Stock Exchange (the “TSX”), and the TSX has accepted, the Company's notice of intention to make a normal course issuer bid (the “TSX NCIB”).
Spinach® vapes, known for exceptional quality, bold flavor profiles and advanced hardware, continue to resonate with adult consumers across Canada Spinach® vapes, known for exceptional quality, bold flavor profiles and advanced hardware, continue to resonate with adult consumers across Canada
Those who have been investing in marijuana stocks over the years have seen many changes. If you have been investing and trading since just before the pandemic, then you know how exciting the sector can be. With all the changes in the cannabis industry, from regulations to federal legislation, hopes are high for investors. At the start, some were filled with doubt about legal cannabis, let alone investing in marijuana stocks.
Many marijuana stock investors have a strong positive outlook on the future of the market. If you've been watching the cannabis sector, then you know how volatile and uncertain trading can be. Yet there have been changes that give more upside to what the future of investing can hold. As cannabis is now a class 3 substance federally, more companies are making shifts in their business to get in line with this new legislation.
Cronos reported strong Q1 performance with record level revenue. International sales are driving growth and the Canadian markets are showing improvement. The company is set to acquire CanAdelaar in the Netherlands which will increase its international operations and revenue potential.
Cronos Group Inc. reported Q1 '26 revenue up 40% to $45 million, exceeding estimates. Despite strong top-line growth, CRON posted a small operating loss of $1.8 million, with net income driven by interest and FX gains. CapEx dropped sharply by 87% year-over-year to $1.9 million, reflecting tighter capital discipline.
Cronos Group Inc. (CRON:CA) Q1 2026 Earnings Call Transcript
Cronos Group NASDAQ: CRON reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued international expansion as key drivers of the quarter.
Cronos Group (CRON) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.02 per share a year ago.
Net revenue in Q1 2026 increased by 40% year-over-year to $45. 2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada1 Ninth consecutive quarter of record net revenue in Israel, where PEACE NATURALS continues to be the number one cannabis brand2 Industry-leading balance sheet with $822 million in total cash and cash equivalents TORONTO, May 11, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc.
Net revenue in Q1 2026 increased by 40% year-over-year to $45.2 million Achieved record net revenue and gross profit in Q1 2026 Reached #1 market share in vapes in Canada 1 Ninth consecutive quarter of record net revenue in Israel, where PEACE NATURALS ® continues to be the number one cannabis brand 2 Industry-leading balance sheet with $822 million in total cash and cash equivalents TORONTO, May 11, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2026 first quarter business results. “Cronos delivered record net revenue and gross profit in the first quarter, as we continue to execute against our borderless products strategy and as additional supply from the expansion at Cronos GrowCo fuels our next phase of growth.